Skip to main content

Published locations for Gefitinib bests chemo as adjuvant therapy for early EGFR-mutant NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Gefitinib bests chemo as adjuvant therapy for early EGFR-mutant NSCLC

User login

  • Reset your password
  • /content/gefitinib-bests-chemo-adjuvant-therapy-early-egfr-mutant-nsclc
  • /oncologypractice/article/138567/lung-cancer/gefitinib-bests-chemo-adjuvant-therapy-early-egfr-mutant
  • /node/155702/article/138567/lung-cancer/gefitinib-bests-chemo-adjuvant-therapy-early-egfr-mutant
  • /hematology-oncology/article/138567/lung-cancer/gefitinib-bests-chemo-adjuvant-therapy-early-egfr
  • /chestphysician/article/138567/lung-cancer/gefitinib-bests-chemo-adjuvant-therapy-early-egfr-mutant